Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-02-17

Clinical Trial Update: Emergence Agitation of Sevoflurane in Pediatric [Phase 2, Phase 3]

View source ↗

Summary

A pediatric Phase 2/3 trial evaluating sevoflurane for emergence agitation (emergence delirium) has an update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sevoflurane (Sevoflurane)

Snippet

Sponsor: Ain Shams University | Conditions: Emergence Delirium | Phase 2, Phase 3 | Status: COMPLETED